In a shareholder derivative suit against members of TransUnion’s board of directors related to a CFPB order, the Delaware Court of Chancery ruled the plaintiffs couldn’t prove that most board members were unable to make fair decisions about the company’s actions.
10/17/2024 3:20 P.M.
1.5 minute read
The Delaware Court of Chancery issued a memorandum opinion (PDF) on Oct. 1 dismissing shareholder claims that members of TransUnion’s board of directors breached their fiduciary duties by failing to prevent purported technical violations of consumer protection laws.
TransUnion, a consumer credit reporting company, submitted to a Consumer Financial Protection Bureau regulatory consent order in 2017 requiring it to change its advertising and billing practices. TransUnion worked to correct these practices with the oversight of its board, but it had a disagreement with the regulator on the details of certain changes.
Because the board learned that the regulator’s views diverged from TransUnion’s, the plaintiffs asserted that the board purposefully violated the law for greater profit.
In response to the lawsuit, TransUnion argued that the Delaware Court of Chancery should dismiss the investors’ claims.
The Decision
The Delaware Court of Chancery dismissed the lawsuit, stating that the board’s disagreements with the CFPB over details like font size and placement of disclosures did not amount to a breach of the board’s duty of loyalty.
It noted that the board took immediate steps to comply with the consent order, including removing certain features from TransUnion’s website and implementing a redress plan. The board also relied on advice from outside counsel, including a former CFPB enforcement attorney, regarding the interpretation of the consent order.
The court found that the board had acted in good faith by trying to comply with the consent order, and any failure in compliance was due to interpretive differences rather than bad faith.
The court pointed out the wide gulf “between imperfect compliance and purposeful lawbreaking.”
ACA’s Take
Regular board-level oversight of compliance efforts is crucial. Ensure that your board receives frequent updates on regulatory matters and compliance initiatives.
Additionally, TransUnion’s documented attempts to address CFPB concerns helped demonstrate good faith. A takeaway for ACA members is to maintain clear records of your compliance efforts and communications with regulators.
Read the memorandum opinion (PDF) here.
Remember, subscribe to ACA Daily and Member Alerts under your My ACA profile when logged in to acainternational.org.
In a shareholder derivative suit against members of TransUnion’s board of directors related to a CFPB order, the Delaware Court of Chancery ruled the plaintiffs couldn’t prove that most board members were unable to make fair decisions about the company’s actions.





